1-10 of 10
Michael J. Schell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma

Available to Purchase
Ahmad A. Tarhini, Zeynep Eroglu, Islam Eljilany, Jonathan S. Zager, Ricardo J. Gonzalez, Amod A. Sarnaik, Carl Wayne Cruse, Nikhil I. Khushalani, Deanryan B. De Aquino, Edith Abraham, Diana M. Acevedo, Allison Richards, Michael J. Schell, Denise Kalos, Pei-Ling Chen, Jane L. Messina, David A. Canton, Vernon K. Sondak
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (23): 5333–5341.
https://doi.org/10.1158/1078-0432.CCR-24-2768
Published: 02 December 2024
View articletitled, Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma
Open the PDF for Neoadjuvant Intratumoral Plasmid IL-12 Electro-Gene-Transfer and Nivolumab in Patients with Operable, Locoregionally Advanced Melanoma in another window
Includes: Supplementary data
Journal Articles

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

Available to Purchase
MacLean S. Hall, John E. Mullinax, Cheryl A. Cox, Amy M. Hall, Matthew S. Beatty, Jamie Blauvelt, Patrick Innamarato, Luz Nagle, Holly Branthoover, Doris Wiener, Benjamin Schachner, Alberto J. Martinez, Allison D. Richards, Carolyn J. Rich, Marjorie Colón Colón, Michael J. Schell, Jamie K. Teer, Nikhil I. Khushalani, Jeffrey S. Weber, James J. Mulé, Vernon K. Sondak, Shari Pilon-Thomas, Amod A. Sarnaik
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (24): 5317–5329.
https://doi.org/10.1158/1078-0432.CCR-22-2103
Published: 15 December 2022
View articletitled, Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma
Open the PDF for Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma in another window
Includes: Supplementary data
Journal Articles

Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Available to Purchase
Christine H. Chung, Jiannong Li, Conor E. Steuer, Priyanka Bhateja, Matthew Johnson, Jude Masannat, Maria I. Poole, Feifei Song, Juan C. Hernandez-Prera, Helen Molina, Bruce M. Wenig, Sunil Kumar, Charlotte Kuperwasser, Philip J. Stephens, Joaquim M. Farinhas, Dong M. Shin, Julie A. Kish, Jameel Muzaffar, Kedar Kirtane, James W. Rocco, Michael J. Schell, Nabil F. Saba, Marcelo Bonomi
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2329–2338.
https://doi.org/10.1158/1078-0432.CCR-21-3849
Published: 01 June 2022
View articletitled, Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
Open the PDF for Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Free
Todd C. Knepper, Meagan Montesion, Jeffery S. Russell, Ethan S. Sokol, Garrett M. Frampton, Vincent A. Miller, Lee A. Albacker, Howard L. McLeod, Zeynep Eroglu, Nikhil I. Khushalani, Vernon K. Sondak, Jane L. Messina, Michael J. Schell, James A. DeCaprio, Kenneth Y. Tsai, Andrew S. Brohl
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2019) 25 (19): 5961–5971.
https://doi.org/10.1158/1078-0432.CCR-18-4159
Published: 01 October 2019
View articletitled, The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy
Open the PDF for The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy in another window
Includes: Supplementary data
Journal Articles

A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome

Free
Michael J. Schell, Mingli Yang, Edoardo Missiaglia, Mauro Delorenzi, Charlotte Soneson, Binglin Yue, Michael V. Nebozhyn, Andrey Loboda, Gregory Bloom, Timothy J. Yeatman
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (3): 734–745.
https://doi.org/10.1158/1078-0432.CCR-15-0143
Published: 31 January 2016
View articletitled, A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome
Open the PDF for A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome in another window
Includes: Supplementary data
Journal Articles

Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma

Free
Geoffrey T. Gibney, Ragini R. Kudchadkar, Ronald C. DeConti, Melissa S. Thebeau, Maria P. Czupryn, Leticia Tetteh, Cabell Eysmans, Allison Richards, Michael J. Schell, Kate J. Fisher, Christine E. Horak, H. David Inzunza, Bin Yu, Alberto J. Martinez, Ibrahim Younos, Jeffrey S. Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4): 712–720.
https://doi.org/10.1158/1078-0432.CCR-14-2468
Published: 16 February 2015
View articletitled, Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma
Open the PDF for Safety, Correlative Markers, and Clinical Results of Adjuvant Nivolumab in Combination with Vaccine in Resected High-Risk Metastatic Melanoma in another window
Journal Articles

A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors

Free
Jhanelle E. Gray, Eric Haura, Alberto Chiappori, Tawee Tanvetyanon, Charles C. Williams, Mary Pinder-Schenck, Julie A. Kish, Jenny Kreahling, Richard Lush, Anthony Neuger, Leticia Tetteh, Angela Akar, Xiuhua Zhao, Michael J. Schell, Gerold Bepler, Soner Altiok
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (6): 1644–1655.
https://doi.org/10.1158/1078-0432.CCR-13-2235
Published: 13 March 2014
View articletitled, A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors
Open the PDF for A Phase I, Pharmacokinetic, and Pharmacodynamic Study of Panobinostat, an HDAC Inhibitor, Combined with Erlotinib in Patients with Advanced Aerodigestive Tract Tumors in another window
Journal Articles

Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia

Free
Douglas K. Graham, Dana B. Salzberg, Joanne Kurtzberg, Susan Sather, Glenn K. Matsushima, Amy K. Keating, Xiayuan Liang, Mark A. Lovell, Sara A. Williams, Thomas L. Dawson, Michael J. Schell, Adil A. Anwar, H. Ralph Snodgrass, H. Shelton Earp
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (9): 2662–2669.
https://doi.org/10.1158/1078-0432.CCR-05-2208
Published: 04 May 2006
View articletitled, Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia
Open the PDF for Ectopic Expression of the Proto-oncogene Mer in Pediatric T-Cell Acute Lymphoblastic Leukemia in another window
Journal Articles

Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer

Free
Mark A. Titus, Michael J. Schell, Fred B. Lih, Kenneth B. Tomer, James L. Mohler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (13): 4653–4657.
https://doi.org/10.1158/1078-0432.CCR-05-0525
Published: 06 July 2005
View articletitled, Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer
Open the PDF for Testosterone and Dihydrotestosterone Tissue Levels in Recurrent Prostate Cancer in another window
Journal Articles

Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer

Free
Mark A. Titus, Christopher W. Gregory, O. Harris Ford, III, Michael J. Schell, Susan J. Maygarden, James L. Mohler
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (12): 4365–4371.
https://doi.org/10.1158/1078-0432.CCR-04-0738
Published: 15 June 2005
View articletitled, Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer
Open the PDF for Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer in another window